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Introduction 
Electrospinning has been widely employed to produce 
fibrous scaffolds for cartilage repair [1,2]. Despite the 
potential of the fibrous scaffolds for cartilage tissue 
repair, a significant limitation is their inherent small 
pore size, limiting cell infiltration, leading to 
inhomogeneities in tissue formation. To overcome this 
limitation, methodologies to increase their pore have 
been developed, however these manipulations generally 
degrade the mechanical properties the final three-
dimensional (3D) scaffolds [3,4]. So, a direct 
incorporation of cells into the fibres during 
electrospinning can be a promising approach to produce 
functional and homogeneous tissue constructs, as it 
overcomes the challenges of cell infiltration into small 
pore sizes by literally surrounding cells with the fibre 
matrix as it is produced. This can be achieved using bio-
electrospraying (BES), a concept first introduced in 
2005 by Jayasinghe, and it enables deposition of living 
cells onto specific targets by exposing the cell 
suspension to an external high intensity electric field 
[5,6]. Since cell exposure to the electric field, as well as 
the shear stress of passing through the BES apparatus 
may affect cell viability and function, the viability of 
post-electrosprayed cells was assessed for several cell 
types, and it was found that cell viability was mostly not 
significantly reduced by the process [7]. To our 
knowledge the electrospraying of chondrocytes has not 
yet been performed. So, in this work, chondrocytes were 
electrosprayed and their viability assessed afterwards to 
ensure that the BES process did not affected cell 
viability and function. 
 
Methods 
Several chondrocyte electrospraying experiments were 
performed by adjusting various process parameters, 
such as voltage (10-25 kV), flow rate (1.5-5 mL/h), 
working distance (5-12.5 cm) between the needle and 
the collector and needle gauge (27-28G). These post-
electrosprayed cells will then be cultured for 24 hours 
and their viability assessed by measuring the cell 
metabolic activity using a resazurin assay. 
 
Results 
Post-electrosprayed chondrocytes possessed 
considerable viability, suggesting that a substantial 
number of cells survived to the electrospraying process. 
It should be noted that the percentage of viability was 
calculated as a ratio of the metabolic activity of the 
electrosprayed chondrocytes and the metabolic activity 
of chondrocytes that did not underwent any process. So, 
it is possible that some chondrocytes may have been lost 
in the electrospraying chamber as a result of the high 
voltages used. 
The different parameters employed did not generate 
significant differences in chondrocyte viability, 
however the high voltage applied using the 28G needle 
(24) led to a significant reduction of viable chondrocytes 
(figure 1). 
 
Figure 1: Influence of the applied voltage on 
chondrocyte viability. Statistical analysis by One-way 
ANOVA followed by post hoc Tukey’s test; *p <0.05. 
 
Discussion 
According to the results obtained, it is possible to infer 
that a considerable number of chondrocytes were able to 
survive to the BES process, regardless of the process 
parameters used, suggesting that this technique is a 
promising solution for cellular incorporation into the 
fibres during the electrospinning of 3D scaffolds. 
Voltages higher than 20 kV should be avoided in the 
future.  
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